Eyes On October M&A activities, Approvals, and more
Last month, we had Eyes On some of the latest approvals, M&A and litigation. Read more about AbbVie, Genentech, Lundbeck, and GSK ...
Check-out What Intel Caught our Eye
Eyes On October M&A activities, Approvals, and more
Eyes on BMS, Pfizer, & Amgen
Eyes on BioPharma Headlines
August News Highlights
Eyes On Industry News & Views
Eyes On the Competition
Eyes on Recent News from BioPharma + a 2023 Top WW 2023 List
Eyes on Pharma Restructures + Pfizer's Clinical SAE
1Q24 BioPharma Deals & Raises
Eyes on Corporate Restructuring
Eyes on Current Events - Deals, Approvals & Operations
Eyes On Healthcare Headlines
Eyes on BioPharma Portfolio Strategies
Eyes on Casgevy, Pfizer & More
Eyes On Current Events
Eyes On Current Events
Heartburn from Zantac